Microporous polycaprolactone matrices for controlled drug delivery

H. I. Chang*, Y. Perrie, A. G A Coombes

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The incorporation and release of a lipophilic steroid (progesterone) from microporous polycaprolactone matrices (MPM), inorder to illustrate the capacity for controlled drug delivery from precipitation cast materials, was reported. It was shown that precipitation casting of MPM occurs by extraction of solvent across a semi-permeable membrane formed at the solution/methanol interface. It was observed that the density of MPM ranged from 0.18-0.33 g/cm3 and increased with increasing concentration of the PCL solution. It was concluded that the drug delivery from precipitation cast, PCL matrices may be controlled by variation of processing parameters such as initial drug loading and the matrix density.

Original languageEnglish
Title of host publicationTransactions - 7th World Biomaterials Congress
Publication statusPublished - 1 Dec 2004
EventTransactions - 7th World Biomaterials Congress - Sydney, United Kingdom
Duration: 17 May 200421 May 2004

Conference

ConferenceTransactions - 7th World Biomaterials Congress
CountryUnited Kingdom
CitySydney
Period17/05/0421/05/04

Fingerprint Dive into the research topics of 'Microporous polycaprolactone matrices for controlled drug delivery'. Together they form a unique fingerprint.

  • Cite this

    Chang, H. I., Perrie, Y., & Coombes, A. G. A. (2004). Microporous polycaprolactone matrices for controlled drug delivery. In Transactions - 7th World Biomaterials Congress